How to Deal with Omicron - Traditional Chinese Medicine - Enhance Human Immunity!
International Journal of TROPICAL DISEASE & Health,
Page 32-37
DOI:
10.9734/ijtdh/2022/v43i1230631
Abstract
COVID-19 has been known as the part of “epidemic disease” in TCM (Traditional Chinese Medicine). The reason is that the human body feels the external toxin and pathogen. The pathogenesis is mainly "wet, heat, poison, stasis, deficiency" and the lesions are the principal in the spleen, lungs, and stomach. There are 4 COVID-19 waves in South Africa including ancestral variants, Beta, Delta, and Omicron. Compared COVID-19 cases of the 4 waves and found the admission rate of Omicron was 4.9%, Delta was 13.7%, and Beta was 18.9% (P<0.001). It also found that 28.8% of inpatients of Omicron were critical patients, while critical inpatients of Beta, and Delta were 60.1% and 66.9% respectively (P<0.001). The infectivity of Omicron is ten times that of Delta. Day on Jan 17, 2022, there were about 125 million omicron infections were diagnosed in the world. The current COVID-19 epidemic situation is frustrating. Today there are still no effective vaccines and targeted therapies for the treatment of COVID-19. Fight against the epidemic diseases in China, 90% of confirmed cases have been treated with TCD. TCD can effectively relieve symptoms, shorten the course of the disease, improve the cure rate, reduce the mortality rate, and promote rehabilitation, the total effective rate is more than 90%. This unique system of TCM has opened a new avenue to fight the novel pandemic.
Keywords:
- Pandemic
- COVID-19
- epidemic disease
- therapies
How to Cite
References
Alexandra Flemming. Omicron, the great escape artist [J]. Nature reviews. Immunology. 2022;22(2):75.
Li Zhang, Qianqian Li,Ziteng Liang, et al. The significant immune escape of pseudotyped SARS-CoV-2 variant omicron [J]. Emerging Microbes & Infections. 2022;11(1):1-5.
Jiahui Chen, Rui Wang, Nancy Benovich Gilby, et al. Omicron Variant (B.1.1.529): Infectivity, Vaccine Breakthrough, and Antibody Resistance [J]. Journal of Chemical Information and Modeling. 2022;62(2):412-422.
Max Kozlov. Omicron's feeble attack on the lungs could make it less dangerous [J]. Nature; 2022.
Kai Kupferschmidt, Gretchen Vogel. Omicron threat remains fuzzy as cases explode [J]. Science. 2022;375(6576):9-10.
Michael Le Page. Stopping coronavirus variants [J]. New Scientist. 2021; 252(3365):8.
Yu-Jie Dai, Shi-Yao Wan, Shuai-Shuai Gong, et al. Recent advances of traditional Chinese medicine on the prevention and treatment of COVID-19 [J]. Chinese Journal of Natural Medicines. 2020;18(12): 1-9.
Hua Luo, Yan Gao, Jian Zou, et al.Refections on treatment of COVID-19 with traditional Chinese medicine [J]. Chin Med. 2020;15:94.
Kaixian Chen, Hongzhuan Chen. Traditional Chinese medicine for combating COVID-19 [J]. Frontiers of Medicine. 2020;14(5):529-532.
Xuedong An, YueHong Zhang, Liyun Duan, et al. The direct evidence and mechanism of traditional Chinese medicine treatment of COVID-19 [J]. Biomedicine & Pharmacotherapy. 2021;111267.
Safaet Alam, Md Moklesur Rahman Sarker, Sadia Afrin, et al. Traditional Herbal Medicines, Bioactive Metabolites, and Plant Products Against COVID-19: Update on Clinical Trials and Mechanism of Actions [J]. Frontiers in Pharmacology. 2021;671498.
Robert L Atmar, Kirsten E Lyke, Meagan E Deming, et al. Homologous and Heterologous Covid-19 Booster Vaccinations [J]. The New England Journal of Medicine; 2022.
Yao KT, Liu MH, Li X, et al. Retrospective clinical analysis of traditional Chinese medicine Lianhua Qingwen granule in treating new coronavirus pneumonia. Chin J Exp Tradit Med Form (Zhongguo Shi Yan Fang Ji Xue Za Zhi). 2020;26(11):8-12. (In Chinese).
Cheng D, Li Y. Clinical analysis and typical case report of 54 patients with COVID-19 treated by Lianhua Gingwen granule [J]. World Chinese Medicine. 2020;15(2):150-154.
Li RF, Hou YL, Huang JC, et al. Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2) [J]. Pharmacol Res. 2020;156:104761.
Duan C, Xia WG, Zheng CJ, et al. Clinical observation of Jinhua Qinggan granule in treating COVID-19 [J]. J Tradit Chin Med (Zhong Yi Za Zhi). 2020;61(17):1473-1477. (In Chinese).
Gong PY, Guo YJ, Li XP, et al. Exploring active compounds of Jinhua Qinggan Granules for prevention of COVID-19 based on network pharmacology and molecular docking [J]. Chin Tradit Herb Drugs (Zhong Cao Yao). 2020;51(7):1685-1693. (In Chinese).
Wang Y, Li X, Zhang JH, et al. Study on the mechanism of Xuanfei Baidu decoction in treating COVID-19 based on network pharmacology. Chin J Chin Materia Medica (Zhongguo Zhong Yao Za Zhi). 2020; 45(10):2249–2256. (In Chinese).
Qingwei Li, Han Wang, Xiuyang Li, et al. The role played by traditional Chinese medicine in preventing and treating COVID-19 in China [J]. Frontiers of Medicine. 2020;14(5):681-688.
-
Abstract View: 63 times
PDF Download: 22 times
